Welcome to Merz North America

Merz North America is a specialty healthcare company dedicated to the development and marketing of innovative quality products for physicians and patients across the US. Our products are distributed through two divisions: Aesthetics and Neurosciences.

News

Merz Names Kristina Yu-Isenberg, Ph.D., Vice President of Medical Affairs North America

Merz today announced Kristina Yu-Isenberg, Ph.D., M.P.H, R.Ph., has been named Vice President of Medical Affairs North America, effective immediately. Dr. Yu-Isenberg oversees medical affairs in North America and is located in the Merz North America headquarters in Raleigh, North Carolina.

Read More

Merz Creates Americas Region, Expands Bob Rhatigan’s Leadership Role

Merz, a global leader in medical aesthetics and neurotoxins, today announced the appointment of Bob Rhatigan as Chief Executive Officer – Americas. Expanding on his leadership of Merz’s North American business, Mr. Rhatigan will now assume responsibility for Latin America as well and will oversee the overall commercial strategy for the newly-created Americas Region. In addition, Frank Brandt-Pollmann has been promoted to Area Vice President – Latin America...

Read More

FDA Approves XEOMIN® (incobotulinumtoxinA) For Adult Patients with Sialorrhea

Merz North America announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for XEOMIN® (incobotulinumtoxinA) for the treatment of chronic sialorrhea, or excessive drooling, in adult patients. XEOMIN is the first and only neurotoxin with this approved indication in the U.S.

Read More